MESO vs REPL: stock comparison and AI forecast
Mesoblast Ltd (MESO) and Replimune Group, Inc. (REPL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MESO Mesoblast Ltd
- Market Cap
- $1.81B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
REPL Replimune Group, Inc.
- Price
- $20.02 +499.4% · 6M
- Market Cap
- $1.90B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MESO and REPL have similar market capitalizations ($1.81B and $1.90B).
- REPL carries 0.83 times debt per unit of equity, against 0.36 times for MESO.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MESO | REPL |
|---|---|---|
| Market Cap | $1.81B | $1.90B |
| P/B Ratio | – | 9.27x |
| EPS | $-0.25 | $-3.02 |
| Book Value/Share | – | $2.16 |
| Revenue/Share | $0.61 | – |
| FCF/Share | – | $-2.56 |
Profitability & Margins
| Metric | MESO | REPL |
|---|---|---|
| ROE | – | -132.4% |
| ROA | – | -72.5% |
| ROIC | – | -82.1% |
| EBT Margin | -357.5% | – |
| Tax Rate | -0.3% | 0.2% |
Financial Health
| Metric | MESO | REPL |
|---|---|---|
| Current Ratio | 1.58x | 7.11x |
| Quick Ratio | 1.41x | 6.90x |
| D/E Ratio | 0.36x | 0.83x |
| Financial Leverage | 1.36x | 1.83x |
| Interest Coverage | – | -22.3x |
| Working Capital | $74M | $278M |
Cash Flow
| Metric | MESO | REPL |
|---|---|---|
| Operating Cash Flow | -$149M | -$246M |
| Free Cash Flow | – | -$243M |
| Capital Spending | – | $3M |
Operational Efficiency
| Metric | MESO | REPL |
|---|---|---|
| Asset Turnover | 0.10x | – |
| Receivables Turnover | 1.8x | – |
| Fixed Assets Turnover | 43.3x | – |
| Days Sales Outstanding | 204 days | – |
Income Statement
| Metric | MESO | REPL |
|---|---|---|
| Total Revenue | $78M | – |
| Operating Income | – | -$270M |
| Net Income | – | -$271M |
| R&D Expense | $127M | $189M |
Dividend & Shareholder Information
| Metric | MESO | REPL |
|---|---|---|
| Shares Outstanding | 128M | 95M |
MESO vs REPL: stock comparison and AI forecast
Which is bigger, MESO or REPL?
MESO and REPL have similar market capitalizations ($1.81B and $1.90B).
Which one does Intratio's AI model rank higher, MESO or REPL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.